BOOTHBAY FUND MANAGEMENT, LLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1549230 NEW YORK, NY

Back to KPTI Full portfolio

Position in KPTI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,190,921

+$126,459 QoQ

Shares Held

213,810

+47.8% QoQ

Ownership

0.943%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Derivatives in KPTI

reported options exposure · as of Mar 31, 2026

CallValue

$1,494,431

CallShares

268,300

PutValue

$1,494,431

PutShares

268,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $541,711,137 across 143 Biotechnology names. KPTI ranks #71 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	472,961	$52,664,207
2	RVMD	Revolution Medicines, Inc.	438,595	$42,653,363
3	EXEL	Exelixis, Inc.	803,866	$34,477,812
4	PCVX	Vaxcyte, Inc.	522,019	$30,334,524
5	MLYS	Mineralys Therapeutics, Inc.	1,001,728	$27,136,811
6	TERN	Terns Pharmaceuticals, Inc.	486,170	$25,630,882
7	CGEM	Cullinan Therapeutics, Inc.	1,112,803	$15,812,930
8	XENE	Xenon Pharmaceuticals Inc.	270,412	$15,724,457

All Filings in KPTI

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,190,921	213,810	-20.3%	Shares	Other	2026-05-15
2026-03-31	$1,494,431	268,300	0.0%	Call	Other	2026-05-15
2026-03-31	$1,494,431	268,300	+85.5%	Put	Other	2026-05-15
2025-12-31	$1,064,462	144,628	—	Shares	Other	2026-02-17
No filing history on record for this holder in this stock.